MedPath

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

Phase 3
Active, not recruiting
Conditions
Polycythemia Vera
Interventions
Drug: Placebo
Registration Number
NCT05210790
Lead Sponsor
Protagonist Therapeutics, Inc.
Brief Summary

The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.

Detailed Description

Phase 3 study in approximately 250 subjects previously diagnosed with polycythemia vera (PV) who require phlebotomy on a routine basis. There is a 32-week period during which rusfertide or placebo will be added-on to each subject's ongoing therapy for polycythemia vera which may include phlebotomy only or phlebotomy plus stable doses of either of hydroxyurea, interferon and/or ruxolitinib. All subjects who successfully complete the double blind 32-week portion of the study will receive rusfertide for 124 weeks. Approximately 6 and 12 months after their last dose of rusfertide, subjects will have a post-study contact (e.g. by phone) for safety.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria

All subjects must meet ALL of the following inclusion criteria to be enrolled. There are additional inclusion criteria.

  • Male and female subjects aged 18 (or the country specific minimum age of consent >18) years or older.

  • Meet revised 2016 World Health Organization (WHO) criteria for the diagnosis of polycythemia vera.

  • At least 3 phlebotomies due to inadequate hematocrit control in 6 months before randomization or at least 5 phlebotomies due to inadequate hematocrit control in 1 year before randomization.

  • CBC values immediately prior to randomization:

    1. Hematocrit <45%,
    2. WBC 4000/μL to 20,000/μL (inclusive), and
    3. Platelets 100,000/μL to 1,000,000/μL (inclusive)
  • Subjects receiving cytoreductive therapy at randomization must be on a stable PV therapy regimen.

  • Subjects treated with phlebotomy alone at randomization must have stopped cytoreductive therapy 2 to 6 months before screening.

Main

Exclusion Criteria

Subjects must meet NONE of the following exclusion criteria to be enrolled. There are additional exclusion criteria.

  • Clinically meaningful laboratory abnormalities at Screening.
  • Subjects who require phlebotomy at hematocrit levels lower than 45%.
  • Clinically significant thrombosis (e.g., deep vein thrombosis or splenic vein thrombosis) within 2 months prior to randomization.
  • Active or chronic bleeding within 2 months prior to randomization.
  • History of invasive malignancies within the last 5 years, except localized cured prostate cancer and cervical cancer.
  • Subjects with in situ or stage 1 squamous cell carcinoma of the skin, in situ or stage 1 basal cell carcinoma of the skin, or in situ melanoma of the skin identified during screen unless the cancer is adequately treated before randomization.
  • Received Busulfan, Pipobroman or 32Phosphorus within 7 months prior to screening.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboRusfertidePlacebo (32 Weeks) - Rusfertide (124 Weeks Open-label)
PlaceboPlaceboPlacebo (32 Weeks) - Rusfertide (124 Weeks Open-label)
RusfertideRusfertideRusfertide (32 Weeks) - Rusfertide (124 Weeks Open-label)
Primary Outcome Measures
NameTimeMethod
Proportion of subjects achieving a response who receive rusfertide compared to placebo.Week 20 through Week 32

Response is defined as absence of phlebotomy eligibility.

Secondary Outcome Measures
NameTimeMethod
Proportion of subjects with HCT values <45% for rusfertide and placebo.Week 0 to Week 32
Comparison of mean number of phlebotomies between rusfertide and placebo.Week 0 to Week 32
Comparison mean change from baseline in total fatigue score based on PROMIS Short Form between rusfertide and placebo.Week 32
Comparison of mean change from baseline in total MFSAF total score.Week 32

Trial Locations

Locations (171)

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Sharp Memorial Hospital

🇺🇸

San Diego, California, United States

Good Samaritan Infusion Center - Thomas

🇺🇸

Cincinnati, Ohio, United States

AP-HP Hopital Saint-Louis

🇫🇷

Paris, France

City of Hope Medical Center, Duarte

🇺🇸

Duarte, California, United States

Infirmary Cancer Care

🇺🇸

Mobile, Alabama, United States

Fondazione IRCCS Policlinico San Matteo

🇮🇹

Pavia, Italy

Centro de Estudios de Investigacion SIYODE

🇲🇽

Madero, Mexico

Albert Schweitzer Ziekenhuis

🇳🇱

Dordrecht, Netherlands

Hospital Quironsalud de Zaragoza

🇪🇸

Zaragoza, Spain

Hospital Germans Trias i Pujol

🇪🇸

Barcelona, Spain

UOC Ematologia e Centro Trapianti AST Pesaro Urbino, Stabilimento Muraglia

🇮🇹

Pesaro, Italy

Hospital Universitario Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Erasmus MC

🇳🇱

Rotterdam, Netherlands

Fondazione Policlinico Univ. A . Gemelli IRCCS

🇮🇹

Roma, Italy

Churchill Hospital

🇬🇧

Oxford, United Kingdom

Hospital Universitari i Politecnic La Fe

🇪🇸

Valencia, Spain

Northwick Park Hospital

🇬🇧

Harrow, United Kingdom

MICS Centrum Medyczne Bydgoszcz

🇵🇱

Bydgoszcz, Poland

Hospital Clinic Barcelona

🇪🇸

Barcelona, Spain

Hospital General Universitario Gregorio Maranon

🇪🇸

Madrid, Spain

Hospital Universitario Ramon y Cajal

🇪🇸

Madrid, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Gazi University Medical Faculty

🇹🇷

Yenimahalle, Ankara, Turkey

Barnet Hospital

🇬🇧

Barnet, United Kingdom

The Royal London Hospital

🇬🇧

London, United Kingdom

Hillingdon Hospital

🇬🇧

Uxbridge, Middlesex, United Kingdom

Pilgrim Hospital

🇬🇧

Boston, United Kingdom

Mission Cancer & Blood

🇺🇸

Des Moines, Iowa, United States

University of Kansas Cancer Center

🇺🇸

Kansas City, Kansas, United States

Rocky Mountain Cancer Centers - Boulder

🇺🇸

Boulder, Colorado, United States

Ege University Hospital Department of Hematology

🇹🇷

Bornova, Izmir, Turkey

University of California, San Francisco

🇺🇸

San Francisco, California, United States

Memorial Sloan Kettering Cancer Center - BASKING RIDGE

🇺🇸

Basking Ridge, New Jersey, United States

ZNA Stuivenberg

🇧🇪

Antwerp, Belgium

Cancer Care Specialists

🇺🇸

Reno, Nevada, United States

Medizinische Universitaet Graz

🇦🇹

Graz, Austria

Centro de Estudios Clinicos SAGA

🇨🇱

Providencia, Santiago, Chile

Biocenter Centro Clinico de Investigacion

🇨🇱

Concepción, Chile

UOC Ematologia - ASST Spedail Civill Brescia

🇮🇹

Brescia, Italy

Klinika Hematologii I Transplantologii - Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdańsk, Poland

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi Oddział

🇵🇱

Łódź, Poland

Hospital de Braga

🇵🇹

Braga, Portugal

Karadeniz Technical University Medical Faculty Farabi Hospital

🇹🇷

Trabzon, Ortahisar, Turkey

Sanko Universitesi tip Fakultesi Ic Hastaliklari Anabilim Dali

🇹🇷

Gaziantep, Sehitkamil, Turkey

Marmara University Pendik Training & Research Hospital

🇹🇷

Istanbul, Turkey

Erciyes Universitesi Tip Fakultesi Hastanesi, Dedeman Hospital

🇹🇷

Kayseri, Turkey

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

HSHS St. Mary's Hospital

🇺🇸

Green Bay, Wisconsin, United States

ONCOResearch Lerchenfeld GmbH

🇩🇪

Hamburg, Germany

East Carolina University

🇺🇸

Greenville, North Carolina, United States

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Krankenhaus der Elisabethinen Linz

🇦🇹

Linz, Austria

Medizinische Universitaet Wien

🇦🇹

Wien, Austria

Klinikum Wels-Grieskirchen Gmb

🇦🇹

Wels, Austria

Centro Medico Inmunocel

🇨🇱

Las Condes, Santiago, Chile

Centre Hospitalier d'Argenteuil

🇫🇷

Argenteuil, France

Centre Hospitalier de Beziers

🇫🇷

Béziers, France

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

HCL Centre Hospitalier Lyon Sud

🇫🇷

Pierre-Bénite, France

Uniklinik RWTH Aachen - Klinik fuer Haematologie, Onkologie, Haemostaseologie und Stammzelltransplantation (Med. Klinik IV)

🇩🇪

Aachen, Germany

Monmouth Medical Center

🇺🇸

Long Branch, New Jersey, United States

Charite Universitaetsmedizin Berlin

🇩🇪

Berlin, Germany

Rutgers Cancer Institute of New Jersey

🇺🇸

New Brunswick, New Jersey, United States

Rocky Mountain Cancer Centers

🇺🇸

Lone Tree, Colorado, United States

BRCR Medical Center

🇺🇸

Plantation, Florida, United States

Memorial Sloan Kettering Cancer Center - MONMOUTH

🇺🇸

Middletown, New Jersey, United States

Kepler Universitaets Klinikum GmbH

🇦🇹

Linz, Austria

AP-HP Hospital Necker-Enfants Malades

🇫🇷

Paris, Cedex 15, France

Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Azienda Ospedaliero - Universitaria Careggi

🇮🇹

Firenze, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SC Ematologia (Padiglione Marcora),

🇮🇹

Milano, Italy

Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi

🇹🇷

Gaziantep, Turkey

HSHS St. Vincent Hospital

🇺🇸

Green Bay, Wisconsin, United States

Memorial Sloan Kettering Cancer Center - BERGEN

🇺🇸

Montvale, New Jersey, United States

Northwestern Memorial Hospital

🇺🇸

Chicago, Illinois, United States

Jewish General Hospital

🇨🇦

Montréal, Quebec, Canada

CHU Angers

🇫🇷

Angers, Cedex 09, France

InVo-Institut fuer Versorgungsforschung in der Onkologie GbR

🇩🇪

Koblenz, Germany

Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz

🇩🇪

Mainz, Germany

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII

🇮🇹

Bergamo, Italy

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im.ks.B.Markiewicza

🇵🇱

Brzozów, Poland

Wojewodzkie Wielospecjalistyczne Centrum, Onkologii i Traumatologii im. M Kopernika w Lodzi

🇵🇱

Lodz, Poland

Centrum Medyczne Melita Medical

🇵🇱

Wrocław, Poland

CHULN - Hospital de Santa Maria

🇵🇹

Lisboa, Portugal

Ankara Universitesi Tip Fakultesi Hematologi Bilim dali Ankara

🇹🇷

Balkiraz, Ankara, Turkey

Pontchartrain Cancer Center

🇺🇸

Hammond, Louisiana, United States

Monmouth Medical Center Southern Campus

🇺🇸

Lakewood, New Jersey, United States

CHU Amiens Picardie - Hopital Sud

🇫🇷

Amiens, France

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

AOU San Luigi Gonzaga Orbassano

🇮🇹

Torino, Italy

AOU Citta della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

Azienda ASST-SETTELAGHI, Ospedale di Circolo e Fond. Macchi di Varese Ospedael Vecchio

🇮🇹

Varese, Italy

Promed P.Lach R.Glowacki Spolka Jawna

🇵🇱

Krakow, Poland

MICS Centrum Medyczne Torun

🇵🇱

Toruń, Poland

Pamukkale University Hospitals

🇹🇷

Pamukkale, Denizli, Turkey

Universitaetsmedizin Greifswald

🇩🇪

Greifswald, Germany

Debreceni Egyetem Klinikai Kozpont

🇭🇺

Debrecen, Hungary

IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadon"

🇮🇹

Meldola, Forli-Cesena, Italy

SUPERARE Centro de Infusion S.A. de C.V.

🇲🇽

Mexico City, Mexico

Boca Clinical Trials Mexico S.C. - Ciudad de Mexico

🇲🇽

Mexico City, Mexico

MTZ Clinical Research Powered by Pratia

🇵🇱

Warszawa, Poland

Conde Hospital Garcia de Orta

🇵🇹

Almada, Portugal

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE

🇵🇹

Porto, Portugal

Oregon Health and Science University (OHSU) Knight Cancer Institute

🇺🇸

Portland, Oregon, United States

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

Oncology Associates of Oregon

🇺🇸

Eugene, Oregon, United States

One Clinical Research

🇦🇺

Nedlands, Perth, Australia

Wiener Gesundheitsverbund-Klinik Hietzing 5-Med.

🇦🇹

Vienna, Austria

Gemeinschaftspraxis Haematologie - Onkologie - Hauptstelle

🇩🇪

Dresden, Germany

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

University of Colorado - Aurora Cancer Center

🇺🇸

Aurora, Colorado, United States

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders)

🇺🇸

Bethesda, Maryland, United States

University College London Hospital

🇬🇧

London, United Kingdom

Royal Free Hospital, Royal Free London NHSFT

🇬🇧

London, United Kingdom

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

Fakultni nemocnice Olomouc

🇨🇿

Olomouc, Czechia

Palo Verde Hematology-Oncology

🇺🇸

Glendale, Arizona, United States

Marin Cancer Care

🇺🇸

Greenbrae, California, United States

California Cancer Associates for Research and Excellence - Fresno

🇺🇸

Fresno, California, United States

City of Hope Medical Center, Lenner

🇺🇸

Irvine, California, United States

University of California, Los Angeles (UCLA) - Medical Center

🇺🇸

Los Angeles, California, United States

University of California, San Diego (UCSD) - Moores Cancer Center

🇺🇸

La Jolla, California, United States

Stanford University

🇺🇸

Palo Alto, California, United States

Pomona Valley Hospital Medical Center

🇺🇸

Pomona, California, United States

City of Hope Medical Center, Upland

🇺🇸

Upland, California, United States

BayCare Suncoast Medical Clinic - Hematology/Oncology

🇺🇸

Saint Petersburg, Florida, United States

Northwestern Medicine Lake Forest Hospital

🇺🇸

Lake Forest, Illinois, United States

Northwest Oncology and Hematology

🇺🇸

Rolling Meadows, Illinois, United States

Orchard Healthcare Research Inc

🇺🇸

Skokie, Illinois, United States

Fort Wayne Medical Oncology and Hematology

🇺🇸

Fort Wayne, Indiana, United States

New York Cancer and Blood Specialists

🇺🇸

Riverhead, New York, United States

Roswell Park Comprehensive Cancer Center

🇺🇸

Buffalo, New York, United States

Memorial Sloan Kettering Cancer Center - COMMACK

🇺🇸

Commack, New York, United States

Memorial Sloan Kettering Cancer Center - WESTCHESTER

🇺🇸

Harrison, New York, United States

Ichan School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center - KOCH

🇺🇸

New York, New York, United States

New York Presbyterian Hospital/Weill Cornell Medical Center

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center - NASSAU

🇺🇸

Uniondale, New York, United States

Good Samaritan Infusion Center - Kenwood

🇺🇸

Cincinnati, Ohio, United States

Gabrail Cancer Center

🇺🇸

Canton, Ohio, United States

TriHealth Cancer Institute - Good Samaritan Hospital

🇺🇸

Cincinnati, Ohio, United States

The Ohio State University

🇺🇸

Columbus, Ohio, United States

Ohio Health Research Institute

🇺🇸

Columbus, Ohio, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

University of Washington - Fred Hutchinson Cancer Center

🇺🇸

Seattle, Washington, United States

Texas Oncology San Antonio

🇺🇸

San Antonio, Texas, United States

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Campus Gasthuisberg

🇧🇪

Leuven, Belgium

University Hospital Gent

🇧🇪

Gent, Belgium

Fakultni nemocnice Brno

🇨🇿

Brno, Czechia

Vseobecna fakultni nemocnice v Praze

🇨🇿

Prague, Czechia

CHU Poitiers

🇫🇷

Poitiers, Cedex, France

Semmelweis Egyetem

🇭🇺

Budapest, Hungary

Markhot Ferenc Oktatokorhaz es Rendelointezet

🇭🇺

Eger, Hungary

Rambam Health Care Campus

🇮🇱

Haifa, Israel

Hadassah Medical Center Ein Karem

🇮🇱

Jerusalem, Israel

Rabin Medical Center - Davidoff Hematology Center

🇮🇱

Petach Tikva, Israel

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Shamir Medical Center (Assaf Harofe)

🇮🇱

Zerifin, Israel

IRCCS Azienda Ospedaliero-Universtaria di Bologna

🇮🇹

Bologna, Italy

Community Cancer Trials of Utah

🇺🇸

Ogden, Utah, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Yale University School of Medicine - Yale Cancer Center

🇺🇸

New Haven, Connecticut, United States

Montefiore Einstein Center for Cancer Care

🇺🇸

Bronx, New York, United States

Wilmot Cancer Institute, University of Rochester

🇺🇸

Rochester, New York, United States

The University of Alberta - Edmonton

🇨🇦

Edmonton, Alberta, Canada

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath